November 30, 2025Journal of Cellular and Molecular MedicineOpen Access

SNHG26 Promotes Colorectal Cancer Progression via CDKN2A ‐Dependent Regulation of Cuproptosis and CD8 + T Cell‐Mediated Immunity

View Full Paper

Ask AI

Bookmark

Cancer progression is influenced by the SNHG26 and CDKN2A axis, enhancing tumour growth mechanisms.
Increased expression of SNHG26 correlated with poor prognosis in colorectal cancer patients.
Analysis using RNA immunoprecipitation showed that SNHG26 stabilizes degradation of CDKN2A mRNA underpins its oncogenic effect.
Findings emphasize the role of SNHG26 in modulating the immune microenvironment and T cell activity.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis revealed that SNHG26 enhances apoptosis and cell proliferation in colorectal cancer, implying immune evasion through CXCL9 regulation.

Cite This Study

Wan et al. (2025) studied this question.

synapsesocial.com/papers/692b9da01d383f2b2a37a378 https://doi.org/10.1111/jcmm.70913

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis revealed that SNHG26 enhances apoptosis and cell proliferation in colorectal cancer, implying immune evasion through CXCL9 regulation.

SNHG26 Promotes Colorectal Cancer Progression via CDKN2A ‐Dependent Regulation of Cuproptosis and CD8 + T Cell‐Mediated Immunity

Key Points

Discussion

Implication

Cite This Study

SNHG26 Promotes Colorectal Cancer Progression via CDKN2A ‐Dependent Regulation of Cuproptosis and CD8 + T Cell‐Mediated Immunity

Key Points

Discussion

Implication

Cite This Study